On the front of it, the Indian Supreme Court’s denial of a patent for Novartis’ new anti-cancer medicine seems like a bad choice. The decision, made just two weeks ago on April 1, would logically...
Solar eclipse to pass through Missouri, April 8
Analyzing fashion in Howl's Moving Castle
Marching band is a performing art, not a sport
College Board changes scoring rubric for AP History exams
Media stereotypes of LGBT characters set misleading standard, isolate viewers